Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples

Identifieur interne : 001263 ( Main/Exploration ); précédent : 001262; suivant : 001264

Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples

Auteurs : J. Van Binsbergen [Pays-Bas] ; W. Keur [Pays-Bas] ; M. V. D. Graaf [Pays-Bas] ; A. Siebelink [Pays-Bas] ; A. Jacobs [Pays-Bas] ; D. De Rijk [Pays-Bas] ; J. Toonen [Pays-Bas] ; L. Zekeng [Allemagne] ; E. Afane Ze [Allemagne] ; L. G Gürtler [Allemagne]

Source :

RBID : ISTEX:68156BC00CA1246053A6AE95494C1CBA547203CE

Descripteurs français

English descriptors

Abstract

It was shown previously that about 97% of the anti-HIV-1 group O strain-positive samples were detected by crossreaction with native HIV-1 gp160 (Van Binsbergen et al., Evaluation of a new third generation anti-HIV-1/anti-HIV-2 assay with increased sensitivity for HIV-1 group O, J. Virol. Methods 60 (1996) 131–137). Fourteen out of 17 new anti-HIV-1 group O positive samples, selected with the Enzygnost HIV-1/2 plus assay, were already reactive when tested with HIV-1 gp160. When tested by the Vironostika HIV Uni-Form II plus O microELISA all 17 samples were reactive, demonstrating the necessity to implement an HIV-1 group O-specific antigen in the assay. On the other hand, it was surprisingly found that 40 out of 43 (93%) of anti-HIV-1 group M-positive samples, belonging to strain A, B, C, D, E or F, were detected by crossreaction with the HIV-1 group O (strain ANT70) synthetic peptide incorporated in the Vironostika HIV Uni-Form II plus O. Only HIV-1 subtype D-positive samples did not react with this peptide, presumably because of the presence of a histidine residue in the immunodominant region of HIV-1 subtype D gp41. Both crossreactions make the Vironostika HIV Uni-Form II plus O microELISA also sensitive for anti-HIV-1-positive samples originating from different geographical regions and resulting from different HIV-1 subtype infections. With an unusual seroconversion panel in which p24 Ag was present persistently, many anti-HIV-1/-2 assays produce alternating positive/negative results in anti-HIV antibody-positive bleeds. It was shown that the use of viral p24 and gp160 in a direct sandwich, allowing detection of anti-HIV IgG and IgM, explains the identification of all anti-HIV-positive bleeds by the Vironostika HIV Uni-Form II plus O. The high sensitivity of the plus O assay was confirmed with clinical samples of a so-called anti-HIV-1 low titer panel. The specificity of the Vironostika HIV Uni-Form II plus O determined in five blood transfusion centers, based on 135 070 tests, was 99.97%.

Url:
DOI: 10.1016/S0166-0934(97)00135-3


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples</title>
<author>
<name sortKey="Van Binsbergen, J" sort="Van Binsbergen, J" uniqKey="Van Binsbergen J" first="J" last="Van Binsbergen">J. Van Binsbergen</name>
</author>
<author>
<name sortKey="Keur, W" sort="Keur, W" uniqKey="Keur W" first="W" last="Keur">W. Keur</name>
</author>
<author>
<name sortKey="V D Graaf, M" sort="V D Graaf, M" uniqKey="V D Graaf M" first="M" last="V. D. Graaf">M. V. D. Graaf</name>
</author>
<author>
<name sortKey="Siebelink, A" sort="Siebelink, A" uniqKey="Siebelink A" first="A" last="Siebelink">A. Siebelink</name>
</author>
<author>
<name sortKey="Jacobs, A" sort="Jacobs, A" uniqKey="Jacobs A" first="A" last="Jacobs">A. Jacobs</name>
</author>
<author>
<name sortKey="De Rijk, D" sort="De Rijk, D" uniqKey="De Rijk D" first="D" last="De Rijk">D. De Rijk</name>
</author>
<author>
<name sortKey="Toonen, J" sort="Toonen, J" uniqKey="Toonen J" first="J" last="Toonen">J. Toonen</name>
</author>
<author>
<name sortKey="Zekeng, L" sort="Zekeng, L" uniqKey="Zekeng L" first="L" last="Zekeng">L. Zekeng</name>
</author>
<author>
<name sortKey="Afane Ze, E" sort="Afane Ze, E" uniqKey="Afane Ze E" first="E" last="Afane Ze">E. Afane Ze</name>
</author>
<author>
<name sortKey="Gurtler, L G" sort="Gurtler, L G" uniqKey="Gurtler L" first="L. G" last="Gürtler">L. G Gürtler</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:68156BC00CA1246053A6AE95494C1CBA547203CE</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1016/S0166-0934(97)00135-3</idno>
<idno type="url">https://api.istex.fr/document/68156BC00CA1246053A6AE95494C1CBA547203CE/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000032</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000032</idno>
<idno type="wicri:Area/Istex/Curation">000032</idno>
<idno type="wicri:Area/Istex/Checkpoint">000747</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000747</idno>
<idno type="wicri:doubleKey">0166-0934:1997:Van Binsbergen J:reactivity:of:a</idno>
<idno type="wicri:Area/Main/Merge">001367</idno>
<idno type="wicri:Area/Main/Curation">001263</idno>
<idno type="wicri:Area/Main/Exploration">001263</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples</title>
<author>
<name sortKey="Van Binsbergen, J" sort="Van Binsbergen, J" uniqKey="Van Binsbergen J" first="J" last="Van Binsbergen">J. Van Binsbergen</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM Boxtel</wicri:regionArea>
<wicri:noRegion>5281 RM Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Keur, W" sort="Keur, W" uniqKey="Keur W" first="W" last="Keur">W. Keur</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM Boxtel</wicri:regionArea>
<wicri:noRegion>5281 RM Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="V D Graaf, M" sort="V D Graaf, M" uniqKey="V D Graaf M" first="M" last="V. D. Graaf">M. V. D. Graaf</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM Boxtel</wicri:regionArea>
<wicri:noRegion>5281 RM Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Siebelink, A" sort="Siebelink, A" uniqKey="Siebelink A" first="A" last="Siebelink">A. Siebelink</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM Boxtel</wicri:regionArea>
<wicri:noRegion>5281 RM Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jacobs, A" sort="Jacobs, A" uniqKey="Jacobs A" first="A" last="Jacobs">A. Jacobs</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM Boxtel</wicri:regionArea>
<wicri:noRegion>5281 RM Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="De Rijk, D" sort="De Rijk, D" uniqKey="De Rijk D" first="D" last="De Rijk">D. De Rijk</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM Boxtel</wicri:regionArea>
<wicri:noRegion>5281 RM Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Toonen, J" sort="Toonen, J" uniqKey="Toonen J" first="J" last="Toonen">J. Toonen</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM Boxtel</wicri:regionArea>
<wicri:noRegion>5281 RM Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zekeng, L" sort="Zekeng, L" uniqKey="Zekeng L" first="L" last="Zekeng">L. Zekeng</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Max von Pettenkofer Institut, Universität München, D-80336 München</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
<orgName type="university">Université Louis-et-Maximilien de Munich</orgName>
</affiliation>
</author>
<author>
<name sortKey="Afane Ze, E" sort="Afane Ze, E" uniqKey="Afane Ze E" first="E" last="Afane Ze">E. Afane Ze</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Max von Pettenkofer Institut, Universität München, D-80336 München</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
<orgName type="university">Université Louis-et-Maximilien de Munich</orgName>
</affiliation>
</author>
<author>
<name sortKey="Gurtler, L G" sort="Gurtler, L G" uniqKey="Gurtler L" first="L. G" last="Gürtler">L. G Gürtler</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Max von Pettenkofer Institut, Universität München, D-80336 München</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
<orgName type="university">Université Louis-et-Maximilien de Munich</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Virological Methods</title>
<title level="j" type="abbrev">VIRMET</title>
<idno type="ISSN">0166-0934</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1997">1997</date>
<biblScope unit="volume">69</biblScope>
<biblScope unit="issue">1–2</biblScope>
<biblScope unit="page" from="29">29</biblScope>
<biblScope unit="page" to="37">37</biblScope>
</imprint>
<idno type="ISSN">0166-0934</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0166-0934</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino acids</term>
<term>Asian countries</term>
<term>Assay</term>
<term>Binsbergen</term>
<term>Blood bank</term>
<term>Clinical samples</term>
<term>Competitive elisa</term>
<term>Consensus sequences</term>
<term>Elisa</term>
<term>Ghana</term>
<term>Group antigen</term>
<term>Group samples</term>
<term>Gurtler</term>
<term>Histidine residue</term>
<term>Human virus</term>
<term>Immunodominant region</term>
<term>Indirect elisa</term>
<term>Loop peptides</term>
<term>Organon teknika</term>
<term>Other assays</term>
<term>Other seroconversion panels</term>
<term>Other strains</term>
<term>Peptide</term>
<term>Performance panel</term>
<term>Reactive</term>
<term>Reactive samples</term>
<term>Same donor</term>
<term>Seroconversion</term>
<term>Seroconversion panel</term>
<term>Seroconversion panels</term>
<term>Subtype</term>
<term>Subtype samples</term>
<term>Subtyped samples</term>
<term>Third generation assay</term>
<term>Unusual seroconversion panel</term>
<term>Vanden haesevelde</term>
<term>Virological</term>
<term>Virological methods</term>
<term>Vironostika</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Amino acids</term>
<term>Asian countries</term>
<term>Assay</term>
<term>Binsbergen</term>
<term>Blood bank</term>
<term>Clinical samples</term>
<term>Competitive elisa</term>
<term>Consensus sequences</term>
<term>Elisa</term>
<term>Ghana</term>
<term>Group antigen</term>
<term>Group samples</term>
<term>Gurtler</term>
<term>Histidine residue</term>
<term>Human virus</term>
<term>Immunodominant region</term>
<term>Indirect elisa</term>
<term>Loop peptides</term>
<term>Organon teknika</term>
<term>Other assays</term>
<term>Other seroconversion panels</term>
<term>Other strains</term>
<term>Peptide</term>
<term>Performance panel</term>
<term>Reactive</term>
<term>Reactive samples</term>
<term>Same donor</term>
<term>Seroconversion</term>
<term>Seroconversion panel</term>
<term>Seroconversion panels</term>
<term>Subtype</term>
<term>Subtype samples</term>
<term>Subtyped samples</term>
<term>Third generation assay</term>
<term>Unusual seroconversion panel</term>
<term>Vanden haesevelde</term>
<term>Virological</term>
<term>Virological methods</term>
<term>Vironostika</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Ghana</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">It was shown previously that about 97% of the anti-HIV-1 group O strain-positive samples were detected by crossreaction with native HIV-1 gp160 (Van Binsbergen et al., Evaluation of a new third generation anti-HIV-1/anti-HIV-2 assay with increased sensitivity for HIV-1 group O, J. Virol. Methods 60 (1996) 131–137). Fourteen out of 17 new anti-HIV-1 group O positive samples, selected with the Enzygnost HIV-1/2 plus assay, were already reactive when tested with HIV-1 gp160. When tested by the Vironostika HIV Uni-Form II plus O microELISA all 17 samples were reactive, demonstrating the necessity to implement an HIV-1 group O-specific antigen in the assay. On the other hand, it was surprisingly found that 40 out of 43 (93%) of anti-HIV-1 group M-positive samples, belonging to strain A, B, C, D, E or F, were detected by crossreaction with the HIV-1 group O (strain ANT70) synthetic peptide incorporated in the Vironostika HIV Uni-Form II plus O. Only HIV-1 subtype D-positive samples did not react with this peptide, presumably because of the presence of a histidine residue in the immunodominant region of HIV-1 subtype D gp41. Both crossreactions make the Vironostika HIV Uni-Form II plus O microELISA also sensitive for anti-HIV-1-positive samples originating from different geographical regions and resulting from different HIV-1 subtype infections. With an unusual seroconversion panel in which p24 Ag was present persistently, many anti-HIV-1/-2 assays produce alternating positive/negative results in anti-HIV antibody-positive bleeds. It was shown that the use of viral p24 and gp160 in a direct sandwich, allowing detection of anti-HIV IgG and IgM, explains the identification of all anti-HIV-positive bleeds by the Vironostika HIV Uni-Form II plus O. The high sensitivity of the plus O assay was confirmed with clinical samples of a so-called anti-HIV-1 low titer panel. The specificity of the Vironostika HIV Uni-Form II plus O determined in five blood transfusion centers, based on 135 070 tests, was 99.97%.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Pays-Bas</li>
</country>
<region>
<li>Bavière</li>
<li>District de Haute-Bavière</li>
</region>
<settlement>
<li>Munich</li>
</settlement>
<orgName>
<li>Université Louis-et-Maximilien de Munich</li>
</orgName>
</list>
<tree>
<country name="Pays-Bas">
<noRegion>
<name sortKey="Van Binsbergen, J" sort="Van Binsbergen, J" uniqKey="Van Binsbergen J" first="J" last="Van Binsbergen">J. Van Binsbergen</name>
</noRegion>
<name sortKey="De Rijk, D" sort="De Rijk, D" uniqKey="De Rijk D" first="D" last="De Rijk">D. De Rijk</name>
<name sortKey="Jacobs, A" sort="Jacobs, A" uniqKey="Jacobs A" first="A" last="Jacobs">A. Jacobs</name>
<name sortKey="Keur, W" sort="Keur, W" uniqKey="Keur W" first="W" last="Keur">W. Keur</name>
<name sortKey="Siebelink, A" sort="Siebelink, A" uniqKey="Siebelink A" first="A" last="Siebelink">A. Siebelink</name>
<name sortKey="Toonen, J" sort="Toonen, J" uniqKey="Toonen J" first="J" last="Toonen">J. Toonen</name>
<name sortKey="V D Graaf, M" sort="V D Graaf, M" uniqKey="V D Graaf M" first="M" last="V. D. Graaf">M. V. D. Graaf</name>
</country>
<country name="Allemagne">
<region name="Bavière">
<name sortKey="Zekeng, L" sort="Zekeng, L" uniqKey="Zekeng L" first="L" last="Zekeng">L. Zekeng</name>
</region>
<name sortKey="Afane Ze, E" sort="Afane Ze, E" uniqKey="Afane Ze E" first="E" last="Afane Ze">E. Afane Ze</name>
<name sortKey="Gurtler, L G" sort="Gurtler, L G" uniqKey="Gurtler L" first="L. G" last="Gürtler">L. G Gürtler</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001263 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001263 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:68156BC00CA1246053A6AE95494C1CBA547203CE
   |texte=   Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024